GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $140K invested in Galmed Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0.34% less ownership

Funds ownership: 3.7% → 3.37% (-0.34%)

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$48.2K
2
+$19K
3
+$10.7K
4
SS
SBI Securities
Japan
+$3.86K
5
PWA
Physician Wealth Advisors
Utah
+$43

Top Sellers

1
-$16K
2
-$15.9K
3
-$3.68K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$61.8K
SSA
2
Schonfeld Strategic Advisors
New York
$42.7K
Cambridge Investment Research Advisors
3
Cambridge Investment Research Advisors
Iowa
$19K
UBS Group
4
UBS Group
Switzerland
$12.7K
SS
5
SBI Securities
Japan
$3.89K
PWA
6
Physician Wealth Advisors
Utah
$43
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Quebec, Canada
$26
Raymond James Financial
8
Raymond James Financial
Florida
$22
Wells Fargo
9
Wells Fargo
California
$17
Osaic Holdings
10
Osaic Holdings
Arizona
$15
AF
11
Allworth Financial
California
$4
TWC
12
TD Waterhouse Canada
Ontario, Canada
$4
EWP
13
Elevation Wealth Partners
California
$2
DWM
14
Dogwood Wealth Management
Kansas
$2
VF
15
Virtu Financial
New York
–
TSS
16
Two Sigma Securities
New York
–